Testosterone transdermal - ANI Pharmaceuticals/Antares

Drug Profile

Testosterone transdermal - ANI Pharmaceuticals/Antares

Alternative Names: Bio-T-Gel; LibiGel; Male testosterone gel - ANI Pharmaceuticals/Teva Pharmaceuticals USA; Testosterone ATD™ Gel; Testosterone topical gel - ANI Pharmaceuticals/Antares; Testosterone transdermal - Antares/BioSante

Latest Information Update: 28 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Antares Pharma
  • Developer ANI Pharmaceuticals; Teva Pharmaceuticals USA
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Cognition disorders; Female sexual dysfunction; Hypogonadism

Most Recent Events

  • 28 Nov 2017 No recent reports on development identified - Registered for Hypogonadism in USA (Transdermal)
  • 13 May 2015 Testosterone transdermal is no longer licensed to Teva in USA
  • 05 Apr 2015 Testosterone transdermal is still registered for Hypogonadism in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top